Insomnia Pharmacological Treatment Market
Table of Contents
Global Insomnia Pharmacological Treatment Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Insomnia Pharmacological Treatment Market by Value
2.2.1 Global Insomnia Pharmacological Treatment Revenue by Type
2.2.2 Global Insomnia Pharmacological Treatment Market by Value
2.3 Global Insomnia Pharmacological Treatment Market by Sales
2.3.1 Global Insomnia Pharmacological Treatment Sales by Type
2.3.2 Global Insomnia Pharmacological Treatment Market by Sales
3. The Major Driver of Insomnia Pharmacological Treatment Industry
3.1 Historical & Forecast Global Insomnia Pharmacological Treatment Sales and Revenue (2018-2028)
3.2 Largest Application for Insomnia Pharmacological Treatment (2018-2028)
3.3 The Major Downstream Company in China Market 2022
4. Global and Regional Insomnia Pharmacological Treatment Market
4.1 Regional Market Size in Terms of Sales (2022 & 2028)
4.2 Regional Market Share in Terms of Revenue (2022 & 2028)
4.3 Concentration Ratio (CR5& CR10) of Insomnia Pharmacological Treatment Market
4.4 Mergers & Acquisitions, Expansion Plans
5. US Insomnia Pharmacological Treatment Sales (2018-2028)
5.1 Current and Estimated Sales Breakdown by Type (2018-2028)
5.2 Current and Estimated Sales Breakdown by Application (2018-2028)
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
6. Europe Insomnia Pharmacological Treatment Sales (2018-2028)
6.1 Current and Estimated Sales Breakdown by Type (2018-2028)
6.2 Current and Estimated Sales Breakdown by Application (2018-2028)
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
7. China Insomnia Pharmacological Treatment Sales (2018-2028)
7.1 Current and Estimated Sales Breakdown by Type (2018-2028)
7.2 Current and Estimated Sales Breakdown by Application (2018-2028)
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
8. Japan Insomnia Pharmacological Treatment Sales (2018-2028)
8.1 Current and Estimated Sales Breakdown by Type (2018-2028)
8.2 Current and Estimated Sales Breakdown by Application (2018-2028)
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
9. India Insomnia Pharmacological Treatment Sales (2018-2028)
9.1 Current and Estimated Sales Breakdown by Type (2018-2028)
9.2 Current and Estimated Sales Breakdown by Application (2018-2028)
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
10. Korea Insomnia Pharmacological Treatment Sales (2018-2028)
10.1 Current and Estimated Sales Breakdown by Type (2018-2028)
10.2 Current and Estimated Sales Breakdown by Application (2018-2028)
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
11. Southeast Asia Insomnia Pharmacological Treatment Sales (2018-2028)
11.1 Current and Estimated Sales Breakdown by Type (2018-2028)
11.2 Current and Estimated Sales Breakdown by Application (2018-2028)
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
12. South America Insomnia Pharmacological Treatment Sales (2018-2028)
12.1 Current and Estimated Sales Breakdown by Type (2018-2028)
12.2 Current and Estimated Sales Breakdown by Application (2018-2028)
12.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
12.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
13. Global Insomnia Pharmacological Treatment Average Price Trend
13.1 Market Price for Each Type of Insomnia Pharmacological Treatment in US (2018-2022)
13.2 Market Price for Each Type of Insomnia Pharmacological Treatment in Europe (2018-2022)
13.3 Market Price for Each Type of Insomnia Pharmacological Treatment in China (2018-2022)
13.4 Market Price for Each Type of Insomnia Pharmacological Treatment in Japan (2018-2022)
13.5 Market Price for Each Type of Insomnia Pharmacological Treatment in India (2018-2022)
13.6 Market Price for Each Type of Insomnia Pharmacological Treatment in Korea (2018-2022)
13.7 Market Price for Each Type of Insomnia Pharmacological Treatment in Southeast Asia (2018-2022)
13.8 Market Price for Each Type of Insomnia Pharmacological Treatment in South America (2018-2022)
14. Industrial Chain (Impact of COVID-19)
14.1 Insomnia Pharmacological Treatment Industrial Chain Analysis
14.2 Downstream
14.3 Impact of COVID-19
14.4 Post-pandemic Era
14.5 Technology Trends of Insomnia Pharmacological Treatment
15. Insomnia Pharmacological Treatment Competitive Landscape
15.1 Eisai, Co. Ltd.(Japan)
15.1.1 Eisai, Co. Ltd.(Japan) Company Profiles
15.1.2 Eisai, Co. Ltd.(Japan) Product Introduction
15.1.3 Eisai, Co. Ltd.(Japan) Insomnia Pharmacological Treatment Sales, Revenue (2018-2022)
15.1.4 Strategic initiatives
15.2 Merck & Co., Inc(US)
15.2.1 Merck & Co., Inc(US) Company Profiles
15.2.2 Merck & Co., Inc(US) Product Introduction
15.2.3 Merck & Co., Inc(US) Insomnia Pharmacological Treatment Sales, Revenue (2018-2022)
15.2.4 Strategic initiatives
15.3 Meda Consumer Healthcare Inc(US)
15.3.1 Meda Consumer Healthcare Inc(US) Company Profiles
15.3.2 Meda Consumer Healthcare Inc(US) Product Introduction
15.3.3 Meda Consumer Healthcare Inc(US) Insomnia Pharmacological Treatment Sales, Revenue (2018-2022)
15.3.4 Strategic initiatives
15.4 Pfizer, Inc(US)
15.4.1 Pfizer, Inc(US) Company Profiles
15.4.2 Pfizer, Inc(US) Product Introduction
15.4.3 Pfizer, Inc(US) Insomnia Pharmacological Treatment Sales, Revenue (2018-2022)
15.4.4 Strategic initiatives
15.5 Sanofi(France)
15.5.1 Sanofi(France) Company Profiles
15.5.2 Sanofi(France) Product Introduction
15.5.3 Sanofi(France) Insomnia Pharmacological Treatment Sales, Revenue (2018-2022)
15.5.4 Strategic initiatives
15.6 Takeda Pharmaceutical Company Ltd.(Japan)
15.6.1 Takeda Pharmaceutical Company Ltd.(Japan) Company Profiles
15.6.2 Takeda Pharmaceutical Company Ltd.(Japan) Product Introduction
15.6.3 Takeda Pharmaceutical Company Ltd.(Japan) Insomnia Pharmacological Treatment Sales, Revenue (2018-2022)
15.6.4 Strategic initiatives
15.7 Pernix Therapeutics(US)
15.7.1 Pernix Therapeutics(US) Company Profiles
15.7.2 Pernix Therapeutics(US) Product Introduction
15.7.3 Pernix Therapeutics(US) Insomnia Pharmacological Treatment Sales, Revenue (2018-2022)
15.7.4 Strategic initiatives
15.8 Purdue Pharma L.P(US)
15.8.1 Purdue Pharma L.P(US) Company Profiles
15.8.2 Purdue Pharma L.P(US) Product Introduction
15.8.3 Purdue Pharma L.P(US) Insomnia Pharmacological Treatment Sales, Revenue (2018-2022)
15.8.4 Strategic initiatives
16. Conclusion
17. Methodology and Data Source
List of Tables and Figures
Figure 1. Total Sales by Application of Insomnia Pharmacological Treatment Industry (Volume)
Figure 2. Insomnia Pharmacological Treatment Sales by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2028)
Figure 4. The Top 10 and 5 Players Market Share by Insomnia Pharmacological Treatment Revenue in 2022
Figure 5. US Insomnia Pharmacological Treatment Sales (2018-2028)
Figure 6. Sales Breakdown by Type (%)
Figure 7. Sales Breakdown by Type (%)
Figure 8. Sales Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Insomnia Pharmacological Treatment Sales (2018-2028)
Figure 12. Sales Breakdown by Type (%)
Figure 13. Sales Breakdown by Type (%)
Figure 14. Sales Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Insomnia Pharmacological Treatment Sales (2018-2028)
Figure 18. Sales Breakdown by Type (%)
Figure 19. Sales Breakdown by Type (%)
Figure 20. Sales Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Insomnia Pharmacological Treatment Sales (2018-2028)
Figure 25. Sales Breakdown by Type (%)
Figure 26. Sales Breakdown by Type (%)
Figure 27. Sales Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Insomnia Pharmacological Treatment Sales (2018-2028)
Figure 31. Sales Breakdown by Type (%)
Figure 32. Sales Breakdown by Type (%)
Figure 33. Sales Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Insomnia Pharmacological Treatment Sales (2018-2028)
Figure 37. Sales Breakdown by Type (%)
Figure 38. Sales Breakdown by Type (%)
Figure 39. Sales Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Insomnia Pharmacological Treatment Sales (2018-2028)
Figure 43. Current and Estimated Sales Breakdown by Type (2018-2028)
Figure 44. Sales Breakdown by Type (%)
Figure 45. Sales Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Insomnia Pharmacological Treatment Revenue, by Type (Million USD) (2018-2028)
Table 4. Insomnia Pharmacological Treatment Sales, by Type (K Unit) (2018-2028)
Table 5. Insomnia Pharmacological Treatment Sales (K Unit) by Application (2018-2028)
Table 6. Insomnia Pharmacological Treatment Sales (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Sales (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2028)
Table 10. Ranking of Global Top Insomnia Pharmacological Treatment Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Insomnia Pharmacological Treatment Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 13. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 14. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 15. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Insomnia Pharmacological Treatment Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 19. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 20. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 21. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Insomnia Pharmacological Treatment Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 25. Table Current and Estimated Sales Breakdown by Type
Table 26. Current and Estimated Sales Breakdown by Type
Table 27. Current and Estimated Sales Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Insomnia Pharmacological Treatment Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 30. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 31. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 32. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Insomnia Pharmacological Treatment Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 36. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 37. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 38. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Insomnia Pharmacological Treatment Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 42. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 43. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 44. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Insomnia Pharmacological Treatment Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 48. Table Current and Estimated Sales Breakdown by Type (2018-2028)
Table 49. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Insomnia Pharmacological Treatment in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Insomnia Pharmacological Treatment in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Insomnia Pharmacological Treatment in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Insomnia Pharmacological Treatment in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Insomnia Pharmacological Treatment in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Insomnia Pharmacological Treatment in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Insomnia Pharmacological Treatment in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Eisai, Co. Ltd.(Japan) Profiles
Table 61. Eisai, Co. Ltd.(Japan) Insomnia Pharmacological Treatment Product Introduction
Table 62. Eisai, Co. Ltd.(Japan) Insomnia Pharmacological Treatment Sales (Unit), Revenue (Million USD) (2018-2022)
Table 63. Eisai, Co. Ltd.(Japan) Strategic initiatives
Table 64. Merck & Co., Inc(US) Profiles
Table 65. Merck & Co., Inc(US) Insomnia Pharmacological Treatment Product Introduction
Table 66. Merck & Co., Inc(US) Insomnia Pharmacological Treatment Sales (Unit), Revenue (Million USD) (2018-2022)
Table 67. Merck & Co., Inc(US) Strategic initiatives
Table 68. Meda Consumer Healthcare Inc(US) Profiles
Table 69. Meda Consumer Healthcare Inc(US) Insomnia Pharmacological Treatment Product Introduction
Table 70. Meda Consumer Healthcare Inc(US) Insomnia Pharmacological Treatment Sales (Unit), Revenue (Million USD) (2018-2022)
Table 71. Meda Consumer Healthcare Inc(US) Strategic initiatives
Table 72. Pfizer, Inc(US) Profiles
Table 73. Pfizer, Inc(US) Insomnia Pharmacological Treatment Product Introduction
Table 74. Pfizer, Inc(US) Insomnia Pharmacological Treatment Sales (Unit), Revenue (Million USD) (2018-2022)
Table 75. Pfizer, Inc(US) Strategic initiatives
Table 76. Sanofi(France) Profiles
Table 77. Sanofi(France) Insomnia Pharmacological Treatment Product Introduction
Table 78. Sanofi(France) Insomnia Pharmacological Treatment Sales (Unit), Revenue (Million USD) (2018-2022)
Table 79. Sanofi(France) Strategic initiatives
Table 80. Takeda Pharmaceutical Company Ltd.(Japan) Profiles
Table 81. Takeda Pharmaceutical Company Ltd.(Japan) Insomnia Pharmacological Treatment Product Introduction
Table 82. Takeda Pharmaceutical Company Ltd.(Japan) Insomnia Pharmacological Treatment Sales (Unit), Revenue (Million USD) (2018-2022)
Table 83. Takeda Pharmaceutical Company Ltd.(Japan) Strategic initiatives
Table 84. Pernix Therapeutics(US) Profiles
Table 85. Pernix Therapeutics(US) Insomnia Pharmacological Treatment Product Introduction
Table 86. Pernix Therapeutics(US) Insomnia Pharmacological Treatment Sales (Unit), Revenue (Million USD) (2018-2022)
Table 87. Pernix Therapeutics(US) Strategic initiatives
Table 88. Purdue Pharma L.P(US) Profiles
Table 89. Purdue Pharma L.P(US) Insomnia Pharmacological Treatment Product Introduction
Table 90. Purdue Pharma L.P(US) Insomnia Pharmacological Treatment Sales (Unit), Revenue (Million USD) (2018-2022)
Table 91. Purdue Pharma L.P(US) Strategic initiatives
Industry Market Size
